ArticleCancers2023

Lenalidomide plus Dexamethasone Combination as First-Line Oral Therapy of Multiple Myeloma Patients: A Unicentric Real-Life Study.

Vittorio Del Fabro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.